ProShares Ultra Nasdaq Biotechnology
Limited financial coverage for BIB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors.
- IPO
- 2010
- HQ
- Bethesda, MD, US
Get TickerSpark's AI analysis on BIB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $96.32M
- Div Yield
- 0.41%
- 52W High
- $126.40
- 52W Low
- $54.56
- 50D MA
- $98.96
- 200D MA
- $85.88
- Beta
- 1.20
- RSI (14)
- 66
- Avg Volume
- 11.00K
No earnings-call transcripts are available for BIB yet.
- Free Float
- 0.0%
- Shares Outstanding
- 810.03K
- Float Shares
- 0
of shares held by institutions
21 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bks Advisors, LLC | 15.39K | ▼ 500 |
| Ladenburg Thalmann Financial Services Inc. | 600 | ▲ 500 |
| Advisor Group, Inc. | 200 | 0 |
Our BIB coverage
Recent articles, reports, and earnings notes.
No research on BIB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIB report →ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average – What’s Next?
defenseworld.net · Mar 20
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above 50 Day Moving Average – Here’s Why
defenseworld.net · Dec 20
BIB: A Tactical 2 X Leveraged Biotech ETF
seekingalpha.com · Oct 23
Wall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
investorplace.com · Mar 25
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
investorplace.com · Feb 22
Equity CEFs/ETFs: Top Picks For 2024 - Part II
seekingalpha.com · Jan 5
The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities
investorplace.com · Dec 20
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
investorplace.com · Dec 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.